Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: AstraZeneca |
Recipient: You |
Company: Lilly |
Recipient: You |
Company: EMD Serono |
Recipient: You |
Company: Spectrum Pharmaceuticals |
Recipient: You |
Company: Daiichi Sankyo/Lilly |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Hengrui Therapeutics |
Recipient: You |
Company: Janssen Oncology |
Recipient: You |
Company: Blueprint Medicines |
Recipient: You |
Company: Abbvie |
Recipient: You |
Company: Arrivent |
Recipient: You |
Company: Regeneron |
Recipient: You |
Company: ABION |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Taiho Pharmaceutical |
Recipient: You |
Company: Systimmune |
Recipient: You |
Company: ArriVent Biopharma |
Recipient: You |
Company: BlossomHill Therapeutics |
Recipient: You |
Company: Black Diamond Therapeutics |
Recipient: You |
Company: Aviston |
Recipient: You |
Company: Allyst |
Recipient: You |
Company: PineTree |
Recipient: You |
Company: Merus |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Eli Lilly |
Recipient: Your Institution |
Company: Boehringer Ingelheim |
Recipient: Your Institution |
Company: arrivent |
Recipient: Your Institution |
Company: Teligene |
Recipient: Your Institution |
Company: Regeneron |
Recipient: Your Institution |
Company: Janssen |
Recipient: Your Institution |
Company: EMD Serono |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Spectrum Pharmaceuticals |
Recipient: You |
Company: EMD Serono |
Recipient: You |
Company: Regeneron |
Recipient: You |
Company: Johnson & Johnson/Janssen |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|